Steven Ryder, MD
Ophthalmology · Charlotte, NCNPI 1366732851
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,685 of the $7,621 with a category attached, or 61.5%. It is spread thinly across 27 manufacturers, the largest accounting for just 22.0%. 2025 is the largest year on record at $2,263, 3.8 times the $602 reported in 2019.
Across 164 payments — averaging $46.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Notal Vision, Inc.$2K
- Davol Inc.$982
- Genentech USA, Inc.$721
- AbbVie$717
- US Retina LLC$641
- Apellis Pharmaceuticals, Inc.$471
- plus $2K from 21 others
Across 40 payments — averaging $38.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$2K
What the payments were for
- Speaking & faculty fees$1,54120%
- Travel & lodging$75410%
- Food & beverage$4,68561%
- Ownership interest$6418%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Notal Vision, Inc. | 14 | $1,680 |
| Davol Inc. | 9 | $982 |
| Genentech USA, Inc. | 17 | $721 |
| AbbVie(2 entities) | 25 | $717 |
| US Retina LLC | 5 | $641 |
| Apellis Pharmaceuticals, Inc. | 12 | $471 |
| Regeneron Healthcare Solutions, Inc. | 15 | $426 |
| Alimera Sciences, Inc. | 12 | $322 |
| Amgen(2 entities) | 5 | $239 |
| Astellas Pharma US Inc | 6 | $212 |
| ANI Pharmaceuticals, Inc. | 6 | $186 |
| Biogen | 5 | $124 |
| Coherus Oncology, Inc. | 6 | $124 |
| Aerie Pharmaceuticals, Inc. | 1 | $122 |
| Spark Therapeutics, Inc. | 1 | $97 |
| Eyepoint US, Inc. | 5 | $82 |
| Bausch & Lomb Americas Inc. | 4 | $75 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
| Novartis | 4 | $70 |
| Genentech, Inc. | 1 | $57 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $50 |
| Tarsus Pharmaceuticals, Inc. | 1 | $40 |
| Rxsight Inc | 2 | $40 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Eyevance Pharmaceuticals LLC | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Rayner Intraocular Lenses Limited | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,621 in reported general payments places this provider in the 85th percentile of 588 ophthalmology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 220 | $8,902 |
| Timolol Maleate | 71 | $1,409 |
| Atropine Sulfate | 11 | $535 |
| Ketorolac Tromethamine | 19 | $477 |
| Brimonidine Tartrate | 53 | $402 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $244 |
| Latanoprost | 31 | $206 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Charlotte
- Thomas MundorfCharlotte$220K
- Charles BlotnickCharlotte$18K
- Adrian ElfersyCharlotte$13K
- Joseph KrugCharlotte$10K
- Royce SyracuseCharlotte$10K
- William HammondsCharlotte$9K
- Preeya GuptaRaleigh$1.8M
- Julie WoodwardDurham$1M
- Rajiv ShahWinston Salem$909K
- Lejla VajzovicDurham$681K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.